DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 40 filers reported holding DECIBEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $458,535 | +27.5% | 119,100 | 0.0% | 0.01% | +10.0% |
| Q1 2023 | $359,682 | +56.7% | 119,100 | +6.4% | 0.01% | +66.7% |
| Q4 2022 | $229,563 | +7.3% | 111,982 | +80.7% | 0.01% | 0.0% |
| Q3 2022 | $214,000 | -54.6% | 61,982 | -44.7% | 0.01% | -45.5% |
| Q2 2022 | $471,000 | +35.0% | 111,982 | -2.6% | 0.01% | +57.1% |
| Q1 2022 | $349,000 | -34.6% | 114,928 | 0.0% | 0.01% | -30.0% |
| Q4 2021 | $534,000 | -39.7% | 114,928 | 0.0% | 0.01% | -41.2% |
| Q3 2021 | $886,000 | +43.1% | 114,928 | +59.6% | 0.02% | +54.5% |
| Q2 2021 | $619,000 | – | 72,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATLAS CAPITAL ADVISORS LLC | 40,000 | $36,400 | 0.01% |